FN2 Earnings Intelligence

Insmed Incorporated earnings overview

Latest Insmed Incorporated (INSM) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportInsmed Incorporated reports Thursday, Oct 29, 2026 · Before market openConsensus EPS $-0.39 · consensus revenue $499.1M
INSM FY2026 Q3 · Calendar Q4 2026

Insmed Incorporated

The quarter supports the view that strong launch execution and resilient demand can underpin continued growth: BRINSUPRI reached blockbuster scale in its first year, guidance increased, and management cited a broad respiratory pipeline. The thesis remains dependent on persistence, regulatory progress, commercialization of new indications and a path to cash-flow positivity.

EPS surprise—
Market move+13.8%

Get the INSM recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.